BR112022009804A2 - Tratamento profilático da pele para radioterapia - Google Patents

Tratamento profilático da pele para radioterapia

Info

Publication number
BR112022009804A2
BR112022009804A2 BR112022009804A BR112022009804A BR112022009804A2 BR 112022009804 A2 BR112022009804 A2 BR 112022009804A2 BR 112022009804 A BR112022009804 A BR 112022009804A BR 112022009804 A BR112022009804 A BR 112022009804A BR 112022009804 A2 BR112022009804 A2 BR 112022009804A2
Authority
BR
Brazil
Prior art keywords
radiotherapy
prophylatic
skin treatment
skin
treatment
Prior art date
Application number
BR112022009804A
Other languages
English (en)
Portuguese (pt)
Inventor
C Wan Derrick
T Longaker Michael
C Gurtner Geoffrey
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of BR112022009804A2 publication Critical patent/BR112022009804A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112022009804A 2019-11-20 2020-10-20 Tratamento profilático da pele para radioterapia BR112022009804A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962938209P 2019-11-20 2019-11-20
PCT/US2020/056421 WO2021101646A1 (en) 2019-11-20 2020-10-20 Prophylactic skin treatment for radiation therapy

Publications (1)

Publication Number Publication Date
BR112022009804A2 true BR112022009804A2 (pt) 2022-08-16

Family

ID=75980773

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022009804A BR112022009804A2 (pt) 2019-11-20 2020-10-20 Tratamento profilático da pele para radioterapia

Country Status (6)

Country Link
US (2) US12403106B2 (cg-RX-API-DMAC7.html)
EP (1) EP4061402A4 (cg-RX-API-DMAC7.html)
JP (2) JP2023503283A (cg-RX-API-DMAC7.html)
CN (1) CN115279394A (cg-RX-API-DMAC7.html)
BR (1) BR112022009804A2 (cg-RX-API-DMAC7.html)
WO (1) WO2021101646A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025111378A1 (en) * 2023-11-20 2025-05-30 Tautona Group Ip Holding Company, L.L.C. Semi-solid formulations of deferoxamine for the treatment of radiation therapy burns

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE26914C (de) 1883-06-19 1884-05-08 CH E. SACKETT in Wayne-Township, Pennsylvanien, V. St. A Ackergeräth zum Pflügen und Zerkleinern der Erde
DK1585548T3 (en) 2002-12-09 2018-09-03 Abraxis Bioscience Llc COMPOSITIONS AND PROCEDURES FOR THE DELIVERY OF PHARMACOLOGICAL AGENTS
US7618615B2 (en) 2004-08-13 2009-11-17 Healthpartners Research Foundation Methods for providing neuroprotection for the animal central nervous system against neurodegeneration caused by ischemia
WO2006034128A2 (en) 2004-09-17 2006-03-30 Angiotech Biomaterials Corporation Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use
WO2006078717A2 (en) * 2005-01-19 2006-07-27 Beth Israel Deaconess Medical Center Lipocalin 2 for the treatment, prevention, and management of cancer metastasis, angiogenesis, and fibrosis
EP3725324A1 (en) 2005-09-16 2020-10-21 Cornell Research Foundation, Inc. Aromatic-cationic peptide for use in a method for reducing cd36 expression
US20100068279A1 (en) 2006-11-28 2010-03-18 Ats Biotech Inc. Burn bandage
US20090069623A1 (en) * 2007-08-21 2009-03-12 Virginia Commonwealth University Intellectual Property Foundation Methods and compositions for treatment or prevention of radiation-induced fibrosis
US20090198332A1 (en) 2008-02-05 2009-08-06 Hilton Becker Method for texturing the surface of a synthetic implant
US10098857B2 (en) * 2008-10-10 2018-10-16 The Board Of Trustees Of The Leland Stanford Junior University Topical and transdermal delivery of HIF-1 modulators to prevent and treat chronic wounds
EP3189836B1 (en) 2009-08-19 2024-01-17 Mordechai Chevion Desferrioxamine-metal complexes for the treatment of immune-related disorders
US8377062B2 (en) 2009-12-17 2013-02-19 Stryker Trauma Gmbh Therapeutic agent capsule for implants
EP2793966B1 (en) 2011-12-22 2018-03-28 Centre Hospitalier Universitaire Vaudois (CHUV) Selective plasma activation for medical implants and wound healing devices
US9737395B2 (en) 2015-06-26 2017-08-22 Phi Nguyen Systems and methods for reducing scarring
US10933174B2 (en) 2016-05-03 2021-03-02 Medtronic, Inc. Hemostatic devices and methods of use

Also Published As

Publication number Publication date
WO2021101646A1 (en) 2021-05-27
US20220409559A1 (en) 2022-12-29
JP2023503283A (ja) 2023-01-27
EP4061402A4 (en) 2023-12-06
EP4061402A1 (en) 2022-09-28
JP2025084944A (ja) 2025-06-03
US20250375400A1 (en) 2025-12-11
CN115279394A (zh) 2022-11-01
US12403106B2 (en) 2025-09-02

Similar Documents

Publication Publication Date Title
MX2023001527A (es) Compuestos con actividad inductora de ferroptosis y metodos de uso de estos.
CR20120638A (es) Métodos de terapia combinada para tratar enfermedades proliferativas
BR112022000019A2 (pt) Composto da fórmula, composição farmacêutica e método de tratamento de câncer
MX2021013830A (es) Inhibidores de ezh2 para tratar linfomas.
BR112021018739A2 (pt) Composições e métodos para o tratamento de doenças ou distúrbios associados a kras
MX2019005465A (es) Metodo de tratamiento de un tumor inmunoterapeutico.
BR112019005930A2 (pt) combinações compreendendo um inibidor de ssao/vap-1 e um inibidor de sglt2, e usos das mesmas
BR112016012713A2 (pt) Método para tratamento de câncer em um paciente necessitado, e, método de selecionar um paciente para um método de tratamento
MX2021006734A (es) Metodo para tratar el cancer.
BR112018005592A8 (pt) Dispositivos e métodos para aprimorar a aplicação tópica de um agente de benefício
BR112017007975A2 (pt) composições e métodos para o tratamento de disfunção das glândulas meibomianas
SV2017005380A (es) Tratamientos conjuntos con anticuerpos anti cd40
BR112017015059A2 (pt) inibidor de proteassoma e uso
BR112021017616A2 (pt) Conjugado de derivado de anticorpo anti-her2-pirrolobenzodiazepina
BR112018001640A2 (pt) combinação de antagonista da pd-1 com um inibidor de egfr
BR112016029334A2 (pt) produto farmacêutico, uso de um anticorpo, kit, método para tratar um paciente com câncer e métodos e usos de novos produtos
MX2014000555A (es) Agentes que se unen a las proteinas de r-espondinas (rspo) y usos de los mismos.
BR112018006039A2 (pt) terapia adjuvante com 25-hidroxivitamina d e artigos para a mesma
BR112015026297A2 (pt) terapia combinada composta por um inibidor tor quinase e um composto de 5-quinazolinona substituído para o tratamento de câncer
BR112019022280A2 (pt) tratamento de cânceres de her2 positivo
CL2020002465A1 (es) Método de tratamiento de enfermedad fibrótica
BR112017009552A8 (pt) Métodos para alvejar o controle transcricional em regiões de super-realçador
BR112015026247A2 (pt) métodos para o tratamento de câncer com o uso de terapia combinada com inibidor de cinase tor
MX2019003722A (es) Composiciones inmunogénicas de tert y métodos de tratamiento que las utilizan.
MX2021003006A (es) Bacterioterapia contra proprionibacterium acnes para el tratamiento de acne.